2

New Horizons in Ophthalmology
From moleculare mechanisms to therapy

New Horizons in Ophthalmology
From moleculare mechanisms to therapy

Datum
27.06.2022, 10:00 - 29.06.2022, 14:00
Hybridevent
Tübingen
Sprache
Englisch
CME Max
12 CME Punkte
Gebühren ab
gebührenfrei
Veranstalter
Universitätsklinik Tübingen
Department für Augenheilkunde
Ophthalmic Research and Vision Science are continuously advancing. We approach a new era, where we are able to analyze, diagnose, treat and eventually prevent eye diseases in a precise and individualized way. This is especially true for retinal diseases, where molecular therapy is now moving into clinical routine. In tune with the focus of activities in Tübingen, the 2nd New Horizons Meeting will concentrate on progress in understanding, diagnosing and treating diseases affecting the retina.
  • Basisinformation
    Datum
    27.06.2022, 10:00 - 29.06.2022, 14:00
    Hybridevent
    Tübingen
    Sprache
    Englisch
    CME Max
    12 CME Punkte
    Gebühren ab
    gebührenfrei
    Veranstalter
    Universitätsklinik Tübingen
    Department für Augenheilkunde
  • VERANSTALTUNGSORT
    University of Tübingen, ETN-Grand Lecture Hall
    Elfriede-Aulhorn-Str. 5-7
    72076 Tübingen, DE
  • Programm

    Online Participation is free of charge after registration at www.horizons2022.de

    MONDAY June 27th 2022

    10:00

    Welcome by the organisers Marius Ueffing
    Ulrich Bartz-Schmidt

    Diagnostics and Therapy of Ocular Tumors
    CHAIRS: Michael Foerster & Ulrich Bartz-Schmidt

    10:10

    Reduction of mortality in uveal melanoma. Dream or reality? Nikolaos E. Bechrakis

    10:30

    Why is the treatment method not decisive for the metastasis of the malignant choroidal melanoma? Heinrich Heimann

    10:50

    Uveal melanoma metastasis - still a secret? Daniela Süsskind

    11:05

    Coffee break  

    11:35

    Clinical challenges in vitreo-retinal lymphoma Vinodh Kakkassery

    12:05

    Molecular genetics of vitreo-retinal lymphoma Falko Fend

    12:30

    Advances in systemic treatment of vitreo-retinal lymphoma Christian Junghanß

    12:50

    Lunch break  

    Diagnostics and Therapy of retinal disease
    CHAIRS: Sabine Aisenbrey & Ulrich Bartz-Schmidt

    14:05

    Routine practice patterns -  Benefit-risk analysis Focke Ziemssen

    14:25

    Managing active macular disorders Andreas Stahl

    14:45

    The german national cohort (NAKO) - importance for ophthalmology Alexandra Schweig

    15:00

    Retinal functional diagnostics: how to measure therapy success? Katarina Stingl

    15:15

    Coffee break  

    15:45

    CRAO - clinical management Martin Spitzer

    16:05

    Limitations, bottlenecks, and new horizons in retina implant ersearch Peter Walter

    16:20

    Sorapazan: an EU clinical study on Stargardt´s disease Tobias Peters

    AI Lecture
    CHAIRS: Nicole Eter & Marius Ueffing

    16:35

    AI for the Eye Philipp Berens

    17:05

    CLOSING TALK: Inspiration-Motivation-"Supervision" - The role of organizations in terms of science in retinal research Franz Badura

    from
    18:00

    RECEPTION@Kerstan Atrium  

    TUESDAY June 28th 2022

    Moleculare mechanisms & Therapy development
    CHAIRS: Franz Holk & Daniel Pauleikhoff

    09:00

    KEYNOTE LECTURE: Age-related macular degeneration genetics meets genome architecture: a merger in the retina Anand Swaroop

    09:30

    Nature & nurture in AMD: where is the potential for the patient? Caroline Klaver

    09:50

    Targeting AMD pathomechanisms for therapy development Sascha Fauser

    10:10

    Classifying AMD Monika Fleckenstein

    10:30

    Imaging endpoints in clinical trials in AMD Steffen Schmitz-Valckenberg

    10:50

    Coffee break  

    Retinal disease and inflammation
    CHAIRS: Marius Ueffing & Simon Clark

    11:20

    Intracellular signaling in response to complement stimulation Olaf Strauss

    11:40

    Mineralocorticoid pathways in the retina Francine Behar-Cohen

    12:00

    Retinal inflammation and AMD Florian Sennlaub

    12:20

    The non-canonical function of CFH in RPE cells and AMD Angela Armento

    12:30

    Removal of RPE lipofuscin as a possible therapy option for Stargardtßs disease and AMD? Sylvie Julien-Schraermeyer

    12:50

    Molecular mechanisms of uveitis Cornelia Deeg

    13:10

    Lunch@Kerstan Atrium  

    Molecular Diagnostics & Therapy development
    CHAIRS: Irene Maumenee & Bernd Wissinger

    14:00

    Selecting the right patient for gene therapy: reflecting genetic results - a critical discourse and species cases Susanne Kohl

    14:15

    Gene-therapy, the next steps ahead? Dominik Fischer

    14:35

    Non-viral transposon-based gene therapy - the efficient alternative approach escaping the immune system Gabriele Thumann

    14:55

    Precision genome surgery for imprecision medicine Stephen Tsang

    15:20

    Coffee break  

    Molecular Therapy Development I
    CHAIRS: Hendrik Scholl & Francois Paquet-Durand

    16:00

    KEYNOTE LECTURE: Expediting AAV gene therapy Alberto Auricchio

    16:30

    Restoring vision with gene and cell therapy Deniz Dalkara

    16:50

    Gene therapy for hearing loss Ellen Reisinger

    17:10

    Targeting proteostasis as mutation independent pharmacological therapy Blanca Arango-Gonzalez

    17:20

    Retinitis pigmentosa: using PKG ingibitors tgo prevent photoreceptor cell death Francois Paquet-Durand

    Molecular Therapy Development II
    CHAIRS: Eberhart Zrenner & Mathias Seeliger

    17:30

    Visual restoration Serge Picaud

    17:50

    Break  

    18:00

    EVENING LECTURE: Optogenetics Botond Roska

    19:00

    Speakers Dinner @ KELTER  

    WEDNESDAY June 29th 2022

    Organoids and cell-based therapy development
    CHAIRS: Thomas Euler & Frank Schaeffel

    09:00

    Regenerating human photoreceptors Volker Busskamp

    09:20

    A glance at the eye in the dish Stefan Liebau

    09:40

    Combining genome editing and retinal organoids for IRDs Vasiliki Kalatzis
    10:00

    Towards modelling and rescue of inherited retinal dystrophies using prime editing and patient-derived iPSCs

    Peter Quinn

    10:20

    Functional analysis of the retina Wadood Haq

    10:35

    Advancing adaptive optics Christina Schwarz

    10:50

    Coffee break  

    Pathomechanisms of retinal disease
    CHAIRS: Knut Stieger & Sven Schnichels

    11:20

    Oxidates stress in AMD pathogenesis Kai Kaarniranta

    11:40

    Proteostasis in the neuroretina Mike Cheetham

    12:00

    A systems view on ciliopathies Ronald Roepman

    12:20

    A mouse model of INPP5E-Leber congenital amaurosis Wolfgang Baehr

    12:40

    SUMMARY & FAREWELL

    Ulrich Bartz-Schmidt
    Marius Ueffing

    13:00

    Light Lunch @ Kerstan Atrium

     

  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    gebührenfrei
    Ärzte/-innen in Weiterbildung
    Gebühren ab
    gebührenfrei
    Studenten/-innen
    Gebühren ab
    gebührenfrei
  • Buchung / Anmeldung

    Bitte wenden Sie sich für weitere Informationen direkt an den Veranstalter

  • Zertifizierung
    Zertifizierung beantragt für 12 CME Punkte bei der Landesärztekammer Baden-Württemberg

Veranstaltung teilen